• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利胆管癌:一项关于临床特征、诊断方式和治疗的全国性调查。结果来自意大利肝病研究协会的“胆管癌”委员会。

Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease.

机构信息

Department of Clinical Medicine, Sapienza University of Rome, Italy.

出版信息

Dig Liver Dis. 2011 Jan;43(1):60-5. doi: 10.1016/j.dld.2010.05.002. Epub 2010 Jun 26.

DOI:10.1016/j.dld.2010.05.002
PMID:20580332
Abstract

BACKGROUND

Very few studies assessed cholangiocarcinoma clinical characteristics.

AIM

To evaluate the clinical characteristics of intra-hepatic (IH) and extra-hepatic (EH)-CCA.

METHODS

We performed a national survey based on a questionnaire.

RESULTS

218 cholangiocarcinomas were observed (47% EH-CCA, 53% IH-CCA) with an age at the diagnosis higher for EH-CCA. Coexistence of cirrhosis or viral cirrhosis was more frequent in IH-CCA than EH-CCA. An incidental asymptomatic presentation occurred in 28% of IH-CCA vs 4% EH-CCA whilst, 74% EH-CCA vs 28% IH-CCA presented with jaundice. 91% of IH-CCA presented as a single intra-hepatic mass, whilst 50% of EH-CCA was peri-hilar. In the diagnostic work-up, 70% of all cholangiocarcinoma cases received at least 3 different imaging procedures. Tissue-proven diagnosis was obtained in 80% cholangiocarcinoma. Open surgery with curative intent was performed in 45% of IH-CCA and 29% EH-CCA. 18% IH-CCA vs 4% EH-CCA did not received treatment.

CONCLUSIONS

In Italy IH-CCA is managed as frequently as EH-CCA. In comparison to EH-CCA, IH-CCA occurs at younger age and is more frequently associated with cirrhosis and with an incidental asymptomatic presentation. In contrast, most EH-CCAs are jaundiced at the diagnosis. Cholangiocarcinoma diagnostic management is cost- and time-consuming with curative surgical treatment applicable more frequently in IH-CCA.

摘要

背景

很少有研究评估胆管癌的临床特征。

目的

评估肝内(IH)和肝外(EH)-CCA 的临床特征。

方法

我们基于问卷进行了一项全国性调查。

结果

观察到 218 例胆管癌(47%为 EH-CCA,53%为 IH-CCA),EH-CCA 的诊断年龄更高。IH-CCA 比 EH-CCA 更常合并肝硬化或病毒性肝硬化。IH-CCA 中有 28%为无症状偶发表现,而 EH-CCA 中仅有 4%为无症状偶发表现,74%的 EH-CCA 表现为黄疸,而 28%的 IH-CCA 表现为黄疸。91%的 IH-CCA 表现为单个肝内肿块,而 50%的 EH-CCA 为肝门周围。在诊断性检查中,所有胆管癌病例中有 70%接受了至少 3 种不同的影像学检查。80%的胆管癌获得了组织学诊断。有 45%的 IH-CCA 和 29%的 EH-CCA 进行了以治愈为目的的开放性手术。18%的 IH-CCA 未接受治疗。

结论

在意大利,IH-CCA 的治疗与 EH-CCA 一样频繁。与 EH-CCA 相比,IH-CCA 发生在更年轻的年龄,更常与肝硬化相关,且更常表现为无症状偶发。相比之下,大多数 EH-CCAs 在诊断时即出现黄疸。胆管癌的诊断性治疗既耗时又费钱,可治愈的手术治疗在 IH-CCA 中更为适用。

相似文献

1
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease.意大利胆管癌:一项关于临床特征、诊断方式和治疗的全国性调查。结果来自意大利肝病研究协会的“胆管癌”委员会。
Dig Liver Dis. 2011 Jan;43(1):60-5. doi: 10.1016/j.dld.2010.05.002. Epub 2010 Jun 26.
2
Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients.多基因突变异质性揭示胆管癌:手术切除患者的临床及预后相关性
Ann Surg Oncol. 2016 May;23(5):1699-707. doi: 10.1245/s10434-015-5046-6. Epub 2015 Dec 30.
3
Genome wide DNA copy number analysis in cholangiocarcinoma using high resolution molecular inversion probe single nucleotide polymorphism assay.使用高分辨率分子倒置探针单核苷酸多态性分析技术对胆管癌进行全基因组DNA拷贝数分析。
Exp Mol Pathol. 2015 Oct;99(2):344-53. doi: 10.1016/j.yexmp.2015.08.003. Epub 2015 Aug 8.
4
Diagnosis and surgical treatment of hepatic hilar cholangiocarcinoma.肝门部胆管癌的诊断与外科治疗
Hepatobiliary Pancreat Dis Int. 2007 Dec;6(6):631-5.
5
Cholangiocarcinoma: Current opinion on clinical practice diagnostic and therapeutic algorithms: A review of the literature and a long-standing experience of a referral center.胆管癌:关于临床实践诊断和治疗算法的当前观点:文献综述及转诊中心的长期经验
Dig Liver Dis. 2016 Mar;48(3):231-41. doi: 10.1016/j.dld.2015.11.017. Epub 2015 Nov 28.
6
Mass-forming intrahepatic cholangiocarcinoma presenting tumor growth in extrahepatic bile duct and superficial spreading.肿块形成型肝内胆管癌表现为肝外胆管肿瘤生长及浅表扩散。
Hepatogastroenterology. 2003 Jan-Feb;50(49):21-3.
7
Cholangiocarcinoma: epidemiology, risk factors, pathogenesis, and diagnosis.胆管癌:流行病学、危险因素、发病机制及诊断
Curr Gastroenterol Rep. 2011 Apr;13(2):182-7. doi: 10.1007/s11894-011-0178-8.
8
Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging.18F-FDG PET-CT在疑似及可能可手术切除的胆管癌中的临床作用:一项与传统成像对比的前瞻性研究
Am J Gastroenterol. 2008 May;103(5):1145-51. doi: 10.1111/j.1572-0241.2007.01710.x. Epub 2008 Jan 2.
9
Clinical presentation, diagnosis, and survival in cholangiocarcinoma: A prospective study.胆管癌的临床表现、诊断及生存情况:一项前瞻性研究。
Arab J Gastroenterol. 2016 Dec;17(4):181-184. doi: 10.1016/j.ajg.2016.10.003. Epub 2016 Nov 30.
10
Comparison of the multidetector-row computed tomography findings of IgG4-related sclerosing cholangitis and extrahepatic cholangiocarcinoma.IgG4相关性硬化性胆管炎与肝外胆管癌的多排螺旋计算机断层扫描结果比较。
Clin Radiol. 2016 Mar;71(3):203-10. doi: 10.1016/j.crad.2015.10.024. Epub 2015 Dec 17.

引用本文的文献

1
Prognosis and Chemotherapeutic Efficacy in Extrahepatic Cholangiocarcinoma With Lung Metastases.肝外胆管癌伴肺转移的预后及化疗疗效
Cancer Rep (Hoboken). 2025 May;8(5):e70236. doi: 10.1002/cnr2.70236.
2
Primary percutaneous stenting above the ampulla versus endoscopic drainage for unresectable malignant hilar biliary obstruction (TESLA RCT): study protocol for a multicenter randomized controlled trial.壶腹上方原发性经皮支架置入术与内镜引流术治疗不可切除性恶性肝门部胆管梗阻的比较(TESLA随机对照试验):一项多中心随机对照试验的研究方案
BMC Cancer. 2025 May 9;25(1):849. doi: 10.1186/s12885-025-14158-0.
3
Treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis: a comprehensive review.
原发性硬化性胆管炎患者胆管癌的治疗:综述
eGastroenterology. 2024 Mar 29;2(1):e100045. doi: 10.1136/egastro-2023-100045. eCollection 2024 Jan.
4
Simultaneous embolization of the right portal and hepatic veins before intrahepatic cholangiocarcinoma resection.肝内胆管癌切除术前同时栓塞右门静脉和肝静脉。
Einstein (Sao Paulo). 2024 Nov 4;22:eRC0524. doi: 10.31744/einstein_journal/2024RC0524. eCollection 2024.
5
Ultrasound-guided percutaneous biopsy for challenging perihilar focal liver lesions: diagnostic accuracy and safety assessment.超声引导下经皮穿刺活检对具有挑战性的肝门部局灶性肝病变:诊断准确性和安全性评估
J Ultrasound. 2024 Nov 2. doi: 10.1007/s40477-024-00949-x.
6
Improvement of survival outcomes of cholangiocarcinoma by ultrasonography surveillance: Multicenter retrospective cohorts.超声监测改善胆管癌生存结局:多中心回顾性队列研究
Heliyon. 2024 Sep 20;10(18):e38191. doi: 10.1016/j.heliyon.2024.e38191. eCollection 2024 Sep 30.
7
Recent Advancement in Diagnosis of Biliary Tract Cancer through Pathological and Molecular Classifications.通过病理和分子分类在胆道癌诊断方面的最新进展
Cancers (Basel). 2024 May 1;16(9):1761. doi: 10.3390/cancers16091761.
8
Current and Future Therapeutic Targets for Directed Molecular Therapies in Cholangiocarcinoma.胆管癌定向分子疗法的当前及未来治疗靶点
Cancers (Basel). 2024 Apr 26;16(9):1690. doi: 10.3390/cancers16091690.
9
Genomic profiling, prognosis, and potential interventional targets in young and old patients with cholangiocarcinoma.老年和年轻胆管癌患者的基因组分析、预后和潜在干预靶点。
Cancer Biol Ther. 2023 Dec 31;24(1):2223375. doi: 10.1080/15384047.2023.2223375.
10
Phosphatidylcholine in bile-derived small extracellular vesicles as a novel biomarker of cholangiocarcinoma.胆汁来源的小细胞外囊泡中的磷脂酰胆碱作为胆管癌的新型生物标志物。
Cancer Med. 2023 Jun;12(12):13007-13018. doi: 10.1002/cam4.5973. Epub 2023 Apr 25.